Full Year Results 

Microgen boosts recurring sales

Microgen boosts recurring sales

Microgen’s (MCGN) sharply improved top line was buoyed by solid organic growth across both of its core businesses in 2017. Alongside contributions from recent acquisitions and solid cash conversion, the market was suitably impressed with the attendant rise in earnings and investors marked the shares up on the publication of preliminary numbers.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now